Yizhen Dong

Partner, Global Founders Capital

Yizhen is a Partner at Global Founders Capital where he leads early stage investments in the frontier of bio, including AI in healthcare innovations, computational biology, synthetic biology, neurotech, medical robotics, and life sciences software. Prior to GFC, Yizhen was a Principal at 11.2 Capital where he led investments in computational biology and synthetic biology. Prior to 11.2 Capital, Yizhen helped launch Avastin in two cancer indications and developed marketing strategies across the product portfolio at Roche/Genentech. Yizhen was formerly a management consultant at ZS Associates after being a trained sushi chef for 7 years. Yizhen graduated magna cum laude in Economics from Vanderbilt University and received his MBA from The University of Chicago Booth School of Business.